Collaboration combines Samsung NeuroLogica’s mobile CT expertise with Accuray’s robotic radiosurgery and motion management ...
Continued investment in Vetter’s broader operational infrastructure accompanies the expansion of its manufacturing capacity.
How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 ...
H. Lundbeck A/S (Lundbeck) announced that it will relocate its US headquarters from Deerfield, Illinois, to Greater Boston, ...
The candidate is the industry's first gut-restricted pan-TRK inhibitor developed for IBS and IBD, targeting a critical ...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration ...
Nutshell Therapeutics (Shanghai) Co., Ltd. ("Nutshell Therapeutics"), an innovative biotech company focused on AI-driven ...
Exclusive agreement adds BoomRay’s preclinical RLT programme to Novartis’ oncology pipeline, with potential milestone ...
The most consequential APAC biopharma deal of 2026 is Sun Pharma's all-cash agreement to buy Organon, which Sun describes as ...
Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research ...
Figure 1. The 2026 approvals timeline: one dot per new active substance, by month and authority. Solid dots are ...
Global study evaluates novel KRAS G12D-targeted protein degrader against docetaxel in previously treated advanced NSCLC, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results